The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
COVID-19의 진행에서 IgM 및 IgG의 혈청유병률 및 동역학
Multicenter Study
[키워드] antibodies
antibody
Antibody testing
antibody tests
association
cause
chemiluminescence
China
clinical
clinical information
cohort study
conducted
contagious
contribute
coronavirus
coronavirus disease
COVID-19
COVID-19 epidemic
COVID-19 patient
COVID-19 patients
cross-sectional
cross-sectional study
demographic data
demonstrated
diagnosis of COVID-19
effective
elicited
enrolled
Epidemic
Follow-up
global pandemic
IgG
IgG and IgM
IgG antibodies
IgG SARS-CoV-2 antibodies
IgM and IgG
information
Interpretation
Kinetics
less
multicentre
Novel coronavirus
outcome
Patient
patients with COVID-19
peak concentration
peak concentrations
progression
reached
regions
Result
sampling
SARS-CoV-2
SARS-CoV-2 antibodies
SARS-CoV-2 antibody
SARS-CoV-2 antibody test
SARS-CoV-2 IgG
SARS-CoV-2 IgM
Seroprevalence
Support
suspected patients
symptom onset
tested
time interval
Treatment
was collected
[DOI] 10.1186/s12865-021-00404-0 PMC 바로가기 [Article Type] Multicenter Study
[DOI] 10.1186/s12865-021-00404-0 PMC 바로가기 [Article Type] Multicenter Study